UAB "PharmaSwiss" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2020 |
|---|
| 9,843,906 |
| 511,106 |
| 387,519 |
| 276,748 |
| 14,369 |
| 39.90 |
| 2.81 |
| 3,137,024 |
| 979,294 |
| 155,997 |
| 4,617,694 |
| 2021 |
|---|
| 10,063,266 |
| 557,213 |
| -454,900 |
| -561,269 |
| -31,078 |
| 35.51 |
| -5.58 |
| 1,975,755 |
| 2,105,923 |
| 0 |
| 4,163,786 |
| 2022 |
|---|
| 1,241,210 |
| 273,394 |
| 1,076,076 |
| 989,337 |
| 217,916 |
| 100.00 |
| 79.71 |
| 2,965,092 |
| 0 |
| 0 |
| 2,965,092 |
Register and
explore Okredo data| 2022 |
|---|
| 1,241,210 |
| 273,394 |
| 1,076,076 |
| 989,337 |
| 217,916 |
| 100.00 |
| 79.71 |
| 2,965,092 |
| 0 |
| 0 |
| 2,965,092 |
Register and
explore Okredo data2022
Turnover (€)
1,241,210 €
-88 % *
Sales per employee (€)
273,394 €-51 % *
Profit before tax (€)
1,076,076 €
337 % *
Net Profit (€)
989,337 €276 % *
Profit per employee (€)
217,916 €801 % *
Total profitability (%)
100.00 %181.61 % *
Net profitability (%)
79.71 %1,528.49 % *
Equity (€)
2,965,092 €50 % *
Amounts Payable And Liabilities (€)
0 €
-100 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
2,965,092 €-29 % *